Analysis of the effectiveness of pharmaceutical service intervention in nebulized inhalation medication for pediatric respiratory system diseases
Objective:To explore the impact of pharmaceutical service intervention on the rationality of pediatric nebulized inhalation medication.Method:Retrospective collection of clinical data from 84 children with respiratory diseases diagnosed and treated in our hospital from January 2022 to December 2022.According to different nursing methods,the patients were divided into a control group(42 cases received routine diagnosis and treatment nursing intervention)and an observation group(42 cases received pharmaceutical service intervention).The unreasonable use of nebulized inhalation medication,the incidence of adverse reactions,and medication compliance were analyzed and compared between the two groups.Result:During the intervention period,the incidence of unreasonable nebulization inhalation medication,such as over indications,inappropriate combination therapy,unreasonable dosage,and improper treatment course,was significantly lower in the observation group than in the control group(P<0.05).The incidence of adverse reactions in the observation group was significantly lower than that in the control group(P<0.05).After intervention,the total medication adherence rate of the observation group was significantly higher than that of the control group(P<0.05).Conclusion:Pharmaceutical service intervention can improve the rationality and safety of pediatric nebulized inhalation medication,and children have good medication compliance.
PediatricsNebulization inhalationPharmaceutical servicesReasonability of medication
NETL
NSTL
万方数据
